Self-Expanding Prostheses for Transcatheter Aortic Valve Replacement

Progress in Cardiovascular Diseases

Volumn 56, Issue 6, 2014, Pages 596-609

  Kumar, Robert ^a   Latib, Azeem ^b   Colombo, Antonio ^b   Ruiz, Carlos E ^c  

^a Sharp Rees Stealy Medical Group   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Aortic stenosis; Aortic valve; Percutaneous; Self expanding; Transcatheter

Indexed keywords

AORTA VALVE STENOSIS; ARTICLE; BLOOD PRESSURE; CLINICAL EFFECTIVENESS; DEVICE APPROVAL; DEVICE SAFETY; DISEASE SEVERITY; EQUIPMENT DESIGN; EVIDENCE BASED MEDICINE; HEART VALVE BIOPROSTHESIS; HIGH RISK PATIENT; HUMAN; MULTICENTER STUDY (TOPIC); PROSTHESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF EXPANDING PROSTHESIS; SURVIVAL; SUTURELESS AORTIC VALVE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VASCULAR DISEASE;

AORTIC STENOSIS; AORTIC VALVE; PERCUTANEOUS; SELF-EXPANDING; TRANSCATHETER;

AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84900023543     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.03.002     Document Type: Article

References (30)

1. Stewart B.F. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997, 29:630-634.
2. Iung B., Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011, 8:162-172.
3. Roberts W.C., Ko J.M. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005, 111:920-925.
4. Bonow R.O., Carabello B.A., Chatterjee K., de Leon A.C., Faxon D.P., Freed M.D., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006, 48:e1-e148.
5. Malaisrie S.C., Tuday E., Lapin B., Wang E., Lee R., McGee E.C., et al. Transcatheter aortic valve implantation decreases the rate of unoperated aortic stenosis. Eur J Cardiothorac Surg 2011, 40(1):43-48.
6. Chieffo A., Buchanan G.L., Van Mieghem N.M., Tchetche D., Dumonteil N., Latib A., et al. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). J Am Coll Cardiol 2013, 61(8):830-836.
7. Tzamtzis S., Viquerat J., Yap J., Mullen M.J., Burriesci G. Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys 2013, 35(1):125-130.
8. Testa L., Latib A., De Marco F., De Carlo M., Agnifili M., Latini R.A., et al. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System. Circulation 2013, 127(12):1300-1307.
9. Bruschi G., De Marco F., Martinelli L., Klugmann S. CoreValve® transcatheter self-expandable aortic bioprosthesis. Expert Rev Med Devices 2013, 10:15-26.
10. Grube E., Naber C., Abizaid A., Sousa E., Mendiz O., Lemos P., et al. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv 2011, 4:751-757.
11. Leon M.B., Piazza N., Nikolsky E., Blackstone E.H., Cutlip D.E., Kappetien A.P., et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials. J Am Coll Cardiol 2011, 57:253-269.
12. Ussia G. TAVI with self-expanding prosthesis: 3-year outcomes from the Italian registry. Presented at EuroPCR 2012, Paris. Paris.
13. Tchetche D., Modine T., Farah B., Vahdat O., Sudre A., Koussa M., et al. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve(R) Accutrak system. EuroIntervention 2012, 8:556-562.
14. Falk V., Walther T., Schwammenthal E., Strauch J., Aicher D., Wahlers T., et al. Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur Heart J 2011, 32(7):878-887.
15. Sundermann S.H., Grunenfelder J., Corti R., Rastan A.J., Linke A., Lange R., et al. Feasibility of the Engager aortic transcatheter valve system using a flexible over-the-wire design. Eur J Cardiothorac Surg 2012, 42:e48-e52.
16. Willson A.B., Rodès-Cabau J., Wood D.A., Leipsic J., Cheung A., Toggweiler S., et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve. J Am Coll Cardiol 2012, 60:581-586.
17. Spence M.S., Lyons K., McVerry F., Smith B., Manoharan G.B., Maguire C., et al. New St. Jude Medical Portico transcatheter aortic valve: features and early results. Minerva Cardioangiol 2013, 61:263-269.
18. Manoharan G., Spence M.S., Rodes-Cabau J., Webb J.G. St. Jude Medical Portico valve. EuroIntervention 2012, 8(Suppl. Q):Q97-Q101.
19. Ribeiro H.B., Urena M., Kuck K.H., Webb J.G., Rodes-Cabau J. Edwards CENTERA valve. EuroIntervention 2012, 8(Suppl. Q):Q79-Q82.
20. Binder R.K., Schafer U., Kuck K.H., Wood D.A., Moss R., Leipsic J., et al. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system. JACC Cardiovasc Interv 2013, 6:301-307.
21. Kempfert J., Mollmann H., Walther T. Symetis ACURATE TA valve. EuroIntervention 2012, 8(Suppl. Q):Q102-Q109.
22. Meredith I.T., Hood K.L., Haratani N., Allocco D.J., Dawkins K.D. Boston Scientific Lotus valve. EuroIntervention 2012, 8(Suppl. Q):Q70-Q74.
23. Gooley R., Lockwood S., Antonis P., Meredith I.T. The SADRA Lotus valve system: a fully repositionable, retrievable prosthesis. Minerva Cardioangiol 2013, 61:45-52.
24. Meredith IT, Worthley SG, Whitbourn RJ, Antonis P, Montarello JK, Newcomb AE, et al. Feasibility study of the repositionable Lotus aortic valve replacement system: 3-month outcomes in 11 patients at high surgical risk (REPRISE I). Presented at TCT 2012, Miami. Available at:. http://www.tctmd.com/show.aspx?id=115120.
25. Kempfert J., Rastan A.J., Mohr F.W., Walther T. A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve™. Eur J Cardiothorac Surg 2011, 40(3):761-763.
26. Treede H., Mohr F.W., Baldus S., Rastan A., Ensminger S., Arnold M., et al. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study. Eur J Cardiothorac Surg 2012, 41:e131-e138.
27. Treede H., Rastan A., Ferrari M., Ensminger S., Figulla H.R., Mohr F.W. JenaValve. EuroIntervention 2012, 8:Q88-Q93.
28. Zannis K., Folliguet T., Laborde F. New sutureless aortic valve prosthesis: another tool in less invasive aortic valve replacement. Curr Opin Cardiol 2012, 27:125-129.
29. Santarpino G., Pfeiffer S., Concistré G., Grossman I., Hinzmann M., Fischlein T. The Perceval S aortic valve has the potential of shortening surgical time: does it also result in improved outcome?. Ann Thorac Surg 2013, 96(1):77-81.
30. Martens S., Sadowski J., Eckstein F.S., Bartus K., Kapelak B., Sievers H.H., et al. Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis. Eur J Cardiothorac Surg 2011, 40(3):749-755.